Glucagon-Like Peptide 1 Receptor Agonists are Associated With Reduced Risk of Hepatic Encephalopathy in Cirrhosis

By afschroeder • May 26, 2026

Singh V, Wang M, Ebinger J, Velazquez A, Cheng S, Kwan AC, Trivedi HD. Glucagon-Like Peptide 1 Receptor Agonists are Associated With Reduced Risk of Hepatic Encephalopathy in Cirrhosis. J Clin Gastroenterol. 2026 May 25. doi: 10.1097/MCG.0000000000002396. Epub ahead of print. PMID: 42183591.

Tags: Cardiology/Epi, Cedars Sinai DoM, Cirrhosis, glp-1 ra, Hepatic encephalopathy, liver cancer, Publications

P2Y12 Inhibitors and Mortality in Patients Hospitalized With Intracerebral Hemorrhage

Jin C, Song Y, Mac Grory B, Sun JL, Alhanti B, Fonarow GC, Schwamm LH, Sheth KN, Smith EE, Messé SR, Saver JL, Bhatt DL,[...]

Clinical Triage of Individuals With Warning Symptoms of Imminent Cardiac Arrest

Reinier K, Chugh H, Kadiyala V, Sargsyan A, Uy-Evanado A, Nakamura K, Heckard E, Mathias M, Grogan T, Elashoff D, Salvucci A, Jui J, Chugh[...]

Nuclear mechanotransduction: tools for mechanical perturbation and chromatin characterization

Soto J, Origer N, Wu Y, Cardenas Benitez B, Massad R, Rahgoshay D, Lee A, Downing T, Li S. Nuclear mechanotransduction: tools for mechanical perturbation[...]